| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 28.813 | 45.981 | 55.519 | 37.440 | 49.219 | 51.715 |
| Total Income - EUR | - | - | - | - | 35.300 | 61.831 | 60.186 | 42.897 | 66.565 | 66.283 |
| Total Expenses - EUR | - | - | - | - | 30.441 | 60.140 | 58.641 | 36.334 | 61.504 | 60.505 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.859 | 1.691 | 1.545 | 6.563 | 5.061 | 5.778 |
| Net Profit/Loss - EUR | - | - | - | - | 4.571 | 1.231 | 1.141 | 6.188 | 4.569 | 4.222 |
| Employees | - | - | - | - | 8 | 8 | 8 | 7 | 6 | 4 |
Check the financial reports for the company - Teomaris Biofructe S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 38.700 | 33.194 | 27.790 | 23.195 | 18.457 | 9.229 |
| Current Assets | - | - | - | - | 12.345 | 10.461 | 17.421 | 20.480 | 12.333 | 16.279 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 7 |
| Receivables | - | - | - | - | 317 | 311 | 304 | 305 | 4.701 | 5.428 |
| Cash | - | - | - | - | 12.028 | 10.151 | 17.118 | 20.175 | 7.633 | 10.845 |
| Shareholders Funds | - | - | - | - | 4.592 | 5.736 | 6.750 | 7.687 | 4.609 | 8.805 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 7.137 | 4.120 | 10.080 | 35.988 | 5.966 | 1.693 |
| Income in Advance | - | - | - | - | 39.317 | 33.798 | 28.382 | 0 | 20.215 | 15.011 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
4391
|
|||||||||
Comments - Teomaris Biofructe S.r.l.